Transjugular intrahepatic portosystemic shunts vs Conventional treatment
Participants without improvement in kidney function · adults with hepatorenal syndrome
Transjugular intrahepatic portosystemic shunts showed no clear difference in participants without improvement in kidney function compared with conventional treatment (low certainty).
1 finding from 1 review
- Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome 2024 · Cochrane Headline outcomes onlyRR 0.53 [0.27, 1.02]1 study · 70 participantsLow